← Back to Search

Procedure

Early Surgical Hematoma Evacuation for Stroke (ENRICH Trial)

N/A
Waitlist Available
Led By Jonathan Ratcliff, MD, MPH
Research Sponsored by Nico Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30, 90, 120, and 180 days
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether early surgery to remove a brain bleed is better than standard medical care.

Eligible Conditions
  • Stroke
  • Intracerebral Hemorrhage

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30, 90, 120, and 180 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30, 90, 120, and 180 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Functional Improvement - mRS
Secondary study objectives
Economic
Safety - Hemorrhage Volume
Safety - Procedure-Related Mortality

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Early Surgical Hematoma EvacuationExperimental Treatment1 Intervention
Subjects will receive early surgical hematoma evacuation using Minimally Invasive Parafascicular Surgery (MIPS).
Group II: Medical ManagementActive Control1 Intervention
Subjects will receive standard of care medical management for ICH.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Early Surgical Hematoma Evacuation
2016
N/A
~300

Find a Location

Who is running the clinical trial?

Nico CorporationLead Sponsor
3 Previous Clinical Trials
131 Total Patients Enrolled
Emory UniversityOTHER
1,697 Previous Clinical Trials
2,603,613 Total Patients Enrolled
32 Trials studying Stroke
350,247 Patients Enrolled for Stroke
Jonathan Ratcliff, MD, MPHPrincipal Investigator1-877-572-5511 | ENRICH@emory.edu | Emory University School of Medicine
~34 spots leftby Nov 2025